Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy-Reference-Cited by-同舟云学术

Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy

Published:2010-08-24 Issue:24 Volume:116 Page:5608-5618
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Glehen Olivier,Gilly François N.,Boutitie Florent,Bereder Jean M.,Quenet François,Sideris Lucas,Mansvelt Baudouin,Lorimier Gérard,Msika Simon,Elias Dominique

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference25 articles.

1. Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia;Glehen;Lancet Oncol.,2004

2. New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome?;Sugarbaker;Lancet Oncol.,2006

3. Eight-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer;Verwaal;Ann Surg Oncol.,2008

4. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for isolated colorectal peritoneal carcinomatosis: experimental therapy or standard of care?;Yan;Ann Surg.,2008

5. A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma;Yan;Ann Oncol.,2007

Cited by 461 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survival Outcomes of Cytoreductive Surgery with HIPEC in Gastric Adenocarcinoma: A National Cancer Database Study;Annals of Surgical Oncology;2024-09-05

2. Impact of obesity after cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for rare peritoneal malignancies: Paradox of obesity or poor prognostic factor?;European Journal of Surgical Oncology;2024-09

3. Effect of RAS and BRAF mutations on peritoneal metastasis risk and cytoreductive surgery/hyperthermic intraperitoneal chemotherapy efficacy in colorectal cancer: A systematic review and meta-analysis;European Journal of Surgical Oncology;2024-09

4. The 2022 PSOGI International Consensus on HIPEC Regimens for Peritoneal Malignancies: HIPEC Technologies;Annals of Surgical Oncology;2024-07-22

5. Consensus Guideline for the Management of Gastric Cancer with Synchronous Peritoneal Metastases;2024-04-21